Advertisement · 728 × 90
#
Hashtag
#BoneMetastases
Advertisement · 728 × 90
Management of bone metastases

Happy Sunday, everyone! Here's another interesting free weekly collection of articles on management of #bonemetastases. Thanks to @biomednews.bsky.social
Sign up to: biomed.news/bims-rebome

4 3 0 0
Management of bone metastases

Good evening! This week's latest free selection of papers on #bonemetastases. Thanks to @biomednews.bsky.social
Sign up to: biomed.news/bims-rebome

1 1 0 0
Preview
U01.20.020 Bone Metastases Study this flashcard to learn the common primary cancers that metastasize to bone, their lesion types (lytic vs. blastic), and key radiologic findings for USMLE Step 1.

Know key cancers causing bone mets—prostate (blastic), breast and lung (lytic). #BoneMetastases #Oncology #USMLE #MedicalEducation #Pathology #Radiology

0 0 0 0
Post image

This research describes the age-related incidence and risk factors of #BrainMetastases in #HepatocellularCarcinoma patients with initial #Lung or #BoneMetastases, urging a reevaluation of screening and prognostic strategies for #HCC. #medsky
Read:
link.springer.com/article/10.1...

0 0 0 0
Post image

The role of bone radiotherapy during immune checkpoint inhibitors treatment of non-small-cell lung cancer: a single-institution experience - May 5, 2025
@journals.sagepub.com @tamedoncol.bsky.social

journals.sagepub.com/doi/10.1177/...

#cancertreatment #NSCLC #bonemetastases #oncsky #oncology

0 0 0 0
Preview
Estela Rodriguez: When more is not necessarily better - SBRT vs conventional RT for Painful Bone Metastases - OncoDaily Estela Rodriguez: When more is not necessarily better - SBRT vs conventional RT for Painful Bone Metastases / cancer, Carole Mercier, Charlotte Billiet, Dirk

When more is not necessarily better: SBRT vs conventional RT for Painful Bone Metastases - Estela Rodriguez
@latinamd.bsky.social

oncodaily.com/insight/293128

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SBRT #RT #Radiotherapy #BoneMetastases

6 0 0 0
Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Lancet Oncol. 2022 Dec;23(12):1499-1507. doi: 10.1016/S1470-2045(22)00642-8. Epub 2022 Nov 4. PMID: 36343655.

Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Lancet Oncol. 2022 Dec;23(12):1499-1507. doi: 10.1016/S1470-2045(22)00642-8. Epub 2022 Nov 4. PMID: 36343655.

[18F]NaF PET-CT could become the preferred method for bone imaging in patients with prostate or breast cancer.
#CancerResearch #BoneMetastases #ProstateCancer #BreastCancer #18FNaF #nucmed #molrad #petct #nuclearmedicine #nuclearradiology #molecularimaging doi: 10.1016/S1470-2045(22)00642-8

2 0 0 0